Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Metformin-induced metabolic reprogramming of chemoresistant ALDHbright breast cancer cells.

Cioce M, Valerio M, Casadei L, Pulito C, Sacconi A, Mori F, Biagioni F, Manetti C, Muti P, Strano S, Blandino G. Metformin-induced metabolic reprogramming of chemoresistant ALDHbright breast cancer cells. Oncotarget. 2014 Jun 30; 5(12):4129-43.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.